| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Jennifer Berry, Ashley Brooks-Russell, Cheryle Beuning, Sarah Limbacher, Tara Lovestead, Kavita M Jeerag. Cannabinoids Detected in Exhaled Breath Condensate after Cannabis Use. Journal of breath research. 2024-07-15. PMID:39008974. |
thc was detected in all ebc samples collected at 0.7 h post use and decreased for all participants at 1.7 h. non-thc cannabinoids were only detected after cannabis use. |
2024-07-15 |
2024-07-18 |
human |
| Jennifer Berry, Ashley Brooks-Russell, Cheryle Beuning, Sarah Limbacher, Tara Lovestead, Kavita M Jeerag. Cannabinoids Detected in Exhaled Breath Condensate after Cannabis Use. Journal of breath research. 2024-07-15. PMID:39008974. |
ebc sampling devices deserve further investigation with respect to modes of cannabis use (e.g., edibles), post use time points, and optimization of cannabinoid recovery. |
2024-07-15 |
2024-07-18 |
human |
| Si Chen, Xilin Li, Qiangen Wu, Yuxi Li, Montserrat Puig, Frederic Moulin, Supratim Choudhuri, Jeremy Gingrich, Lei Gu. Investigation of cannabidiol-induced cytotoxicity in human hepatic cells. Toxicology. 2024-07-14. PMID:39004336. |
cannabidiol (cbd) is one of the primary cannabinoids present in extracts of the plant cannabis sativa l. a cbd-based drug, epidiolex, has been approved by the u.s. fda for the treatment of seizures in childhood-onset epileptic disorders. |
2024-07-14 |
2024-07-18 |
human |
| Xiugong Gao, Kayla Campasino, Miranda R Yourick, Yang Zhao, Estatira Sepehr, Cory Vaught, Robert L Sprando, Jeffrey J Youric. Comparison on the mechanism and potency of hepatotoxicity among hemp extract and its four major constituent cannabinoids. Toxicology. 2024-07-14. PMID:39004335. |
cannabidiol (cbd) has been reported to induce hepatotoxicity in clinical trials and research studies; however, little is known about the safety of other nonintoxicating cannabinoids. |
2024-07-14 |
2024-07-18 |
human |
| Trista Mills, Stephanie Myers, Daniel Hughes, Joseph Wakshla. Tolerability of 2 and 4 mg/kg Dosing Every 12 Hour of a Cannabidiol- and Cannabidiolic Acid-Rich Hemp Extract on Mixed-Breed Dogs Utilized for Teaching in a Closed Colony. Animals : an open access journal from MDPI. vol 14. issue 13. 2024-07-13. PMID:38997975. |
with the increase in popularity of utilizing cannabidiol (cbd) for human ailments, owners are actively interested in the possible utilization of cannabinoid products for their pets. |
2024-07-13 |
2024-07-15 |
human |
| Pearl Shah, Kathryne Holmes, Fairouz Chibane, Phillip Wang, Pablo Chagas, Evila Salles, Melanie Jones, Patrick Palines, Mohamad Masoumy, Babak Baban, Jack Y. Cutaneous Wound Healing and the Effects of Cannabidiol. International journal of molecular sciences. vol 25. issue 13. 2024-07-13. PMID:39000244. |
the focus is on the potential roles of the endocannabinoid system, cannabidiol, and the important immune-regulatory wound cytokine il-33, a member of the il-1 family, and connective tissue growth factor, ctgf, due to their roles in both normal and abnormal wound healing. |
2024-07-13 |
2024-07-15 |
mouse |
| A Isabella Shanker, B U K Li, Robert E Krame. Cannabinoid hyperemesis syndrome co-occurring with superior mesenteric artery syndrome in adolescents. Journal of pediatric gastroenterology and nutrition. 2024-07-12. PMID:38994677. |
both superior mesenteric artery syndrome (smas) and cannabinoid hyperemesis syndrome (chs) may present with abdominal pain, nausea, and emesis - making them difficult to differentiate or determine when they co-occur in adolescents who regularly use cannabis. |
2024-07-12 |
2024-07-14 |
Not clear |
| Kawsar U Chowdhury, Madison Elizabeth Holden, Miles T Wiley, Vishnu Suppiramaniam, Miranda N Ree. Effects of Cannabis on Glutamatergic Neurotransmission: The Interplay between Cannabinoids and Glutamate. Cells. vol 13. issue 13. 2024-07-12. PMID:38994982. |
effects of cannabis on glutamatergic neurotransmission: the interplay between cannabinoids and glutamate. |
2024-07-12 |
2024-07-14 |
Not clear |
| Nicholas J D Wrigh. A review of the direct targets of the cannabinoids cannabidiol, Δ9-tetrahydrocannabinol, N-arachidonoylethanolamine and 2-arachidonoylglycerol. AIMS neuroscience. vol 11. issue 2. 2024-07-11. PMID:38988890. |
a review of the direct targets of the cannabinoids cannabidiol, Δ9-tetrahydrocannabinol, n-arachidonoylethanolamine and 2-arachidonoylglycerol. |
2024-07-11 |
2024-07-13 |
human |
| Nicholas J D Wrigh. A review of the direct targets of the cannabinoids cannabidiol, Δ9-tetrahydrocannabinol, N-arachidonoylethanolamine and 2-arachidonoylglycerol. AIMS neuroscience. vol 11. issue 2. 2024-07-11. PMID:38988890. |
however, research has also revealed that the actions of endocannabinoids, such as anandamide and 2-arachidonoylglycerol, and the phytocannabinoids, tetrahydrocannabinol and cannabidiol, were not just due to interactions with the two cannabinoid receptors but by acting directly on many other targets including various g-protein receptors and cation channels, such as the transient receptor potential channels for example. |
2024-07-11 |
2024-07-13 |
human |
| Zsófia Pénzes, Dorottya Horváth, Petra Molnár, Tünde Fekete, Kitti Pázmándi, Attila Bácsi, Attila Gábor Szöllős. Anandamide modulation of monocyte-derived Langerhans cells: implications for immune homeostasis and skin inflammation. Frontiers in immunology. vol 15. 2024-07-09. PMID:38979427. |
the endocannabinoid system (ecs), named after the chemical compounds found in the cannabis plant, is a regulatory network of neurotransmitters, receptors, and enzymes that plays crucial roles in skin health and disease. |
2024-07-09 |
2024-07-12 |
human |
| Saurabh Kumar Jha, Vinod Kumar Nelson, Punna Rao Suryadevara, Siva Prasad Panda, Chitikela P Pullaiah, Mohana Vamsi Nuli, Mehnaz Kamal, Mohd Imran, Saijyothi Ausali, Mosleh Mohammad Abomughaid, Rashi Srivastava, Rahul Deka, Pingal Pritam, Neha Gupta, Harishankar Shyam, Indrakant K Singh, Bindhy Wasini Pandey, Saikat Dewanjee, Niraj Kumar Jha, Seid Mahdi Jafar. Cannabidiol and Neurodegeneration: From Molecular Mechanisms to Clinical Benefits. Ageing research reviews. 2024-07-05. PMID:38969143. |
cannabidiol is a non-psychotic natural cannabinoid obtained from cannabis sativa that possesses multiple pharmacological actions, including antioxidant, anti-inflammatory, and neuroprotective effects in various nds and other neurological disorders both in vitro and in vivo. |
2024-07-05 |
2024-07-08 |
Not clear |
| Marieka V DeVuono, Mina G Nashed, Mohammed H Sarikahya, Andrea Kocsis, Kendrick Lee, Sebastian R Vanin, Roger Hudson, Eryn P Lonnee, Walter J Rushlow, Daniel B Hardy, Steven R Laviolett. Prenatal tetrahydrocannabinol and cannabidiol exposure produce sex-specific pathophysiological phenotypes in the adolescent prefrontal cortex and hippocampus. Neurobiology of disease. 2024-07-03. PMID:38960101. |
to investigate this, a rat model of prenatal cannabinoid exposure was utilized to examine the impacts of specific cannabis constituents (Δ9-tetrahydrocannabinol [thc]; cannabidiol [cbd]) alone and in combination on future neuropsychiatric liability in male and female offspring. |
2024-07-03 |
2024-07-10 |
rat |
| Mariam Melkumyan, Vibha M Annaswamy, Alexandra M Evans, Opeyemi F Showemimo, Zari E McCullers, Dongxiao Sun, Terrence E Murphy, Kent E Vrana, Amy C Arnold, Wesley M Raup-Konsavage, Yuval Silberma. Effects of cannabidiol, with and without ∆9-tetrahydrocannabinol, on anxiety-like behavior following alcohol withdrawal in mice. Frontiers in neuroscience. vol 18. 2024-07-03. PMID:38957186. |
we hypothesized that cannabinoids, such as cannabidiol (cbd) and ∆9-tetrahydrocannabinol (thc), which are thought to reduce neuroinflammation and anxiety, may have potential utility to alleviate alcohol withdrawal-induced stress-sensitivity and anxiety-like behaviors via modulation of cea neuroimmune function. |
2024-07-03 |
2024-07-06 |
mouse |
| Willi Schirmer, Ilche Gjuroski, Martina Vermathen, Julien Furrer, Stefan Schürch, Wolfgang Weinman. Isolation and characterization of synthesis intermediates and side products in hexahydrocannabiphorol. Drug testing and analysis. 2024-07-01. PMID:38948934. |
the presence of abnormal cannabinoids (abn-hhcp) and bisalkylated cannabinoids is a confirmation that this sample was produced purely synthetically as initially suspected, as these compounds have not been reported in cannabis. |
2024-07-01 |
2024-07-03 |
Not clear |
| Samuel J Stellpflug, Andrew Stolbach, Joe Ghorayeb, Erik Magraken, Eric Twohey, Jeff Lapoint, Kevin deWebe. Cannabis in Combat Sports: position statement of the association of ringside physicians. The Physician and sportsmedicine. 2024-07-01. PMID:38949963. |
and arp position statementbased on the available body of scientific evidence and with the goals of promoting safety of combat sports athletes and striving for the advancement of clean sport, the association of ringside physicians recommends the following regarding cannabis:●use of marijuana or synthetic cannabinoids by combat sports athletes is discouraged due to unproven benefits and many known adverse effects. |
2024-07-01 |
2024-07-04 |
Not clear |
| Anca Maglaviceanu, Miki Peer, Jason Rockel, Robert P Bonin, Mary-Ann Fitzcharles, Karim S Ladha, Anuj Bhatia, Timothy Leroux, Lakshmi Kotra, Mohit Kapoor, Hance Clark. The State of Synthetic Cannabinoid Medications for the Treatment of Pain. CNS drugs. 2024-07-01. PMID:38951463. |
synthetic cannabinoids are compounds made in the laboratory to structurally and functionally mimic phytocannabinoids from the cannabis sativa l. plant, including delta-9-tetrahydrocannabinol (thc). |
2024-07-01 |
2024-07-04 |
Not clear |
| Udo Bonne. Cannabis hyperemesis syndrome recovers completely when the use of cannabis or synthetic cannabinoids is permanently discontinued-cyclic vomiting syndrome does not. Gastroenterology. 2024-06-30. PMID:38945497. |
cannabis hyperemesis syndrome recovers completely when the use of cannabis or synthetic cannabinoids is permanently discontinued-cyclic vomiting syndrome does not. |
2024-06-30 |
2024-07-03 |
Not clear |
| Xuejing Dai, Yi Liu, Yusi Wu, Shubin Wang, Qing Guo, Xuexiang Feng, Feilong Zhao, Ying Li, Lan Lan, Xiaohui L. DYZY01 alleviates pulmonary hypertension via inhibiting endothelial cell pyroptosis and rescuing endothelial dysfunction. European journal of pharmacology. 2024-06-28. PMID:38942262. |
dyzy01 is a new drug whose main ingredient is high-purity cannabidiol, a non-psychoactive constituent of cannabinoids that was demonstrated to have anti-inflammatory and anti-pyroptosis properties. |
2024-06-28 |
2024-07-01 |
human |
| Marta Kruk-Slomka, Tomasz Slomka, Grazyna Bial. The Influence of an Acute Administration of Cannabidiol or Rivastigmine, Alone and in Combination, on Scopolamine-Provoked Memory Impairment in the Passive Avoidance Test in Mice. Pharmaceuticals (Basel, Switzerland). vol 17. issue 6. 2024-06-27. PMID:38931476. |
the aim of the present study was to determine for the first time the effect of administration of natural cannabinoid compound (cannabidiol, cbd) and rivastigmine alone and in combination on the memory disorders connected with cholinergic dysfunctions in mice, provoked by using an antagonist of muscarinic cholinergic receptor-scopolamine. |
2024-06-27 |
2024-06-29 |
mouse |